Evidence that the amino acid region 124-203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection

被引:25
|
作者
Simard, C
Nadon, F
Seguin, C
Trudel, M
机构
[1] Centre de Recherche en Virologie, Institut Armand-Frappier, Université du Québec, Ville de Laval, Que. H7V 1B7, 531 Boulevard des Prairies, Laval des Rapides
基金
英国医学研究理事会;
关键词
respiratory syncytial virus (RSV); polypeptide G; truncated; recombinant vaccine;
D O I
10.1016/0166-3542(95)00053-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The first 230 residues of the 298-amino acid glycoprotein G of respiratory syncytial virus (RSV) are sufficient to confer complete resistance to challenge with live RSV, whereas the first 180 residues completely failed (Olmsted et al. (1989) J. Virol. 63, 411-420). The characterization of a protective epitope corresponding to the amino acid region 174-187 of the G protein (Trudel et al. (1991) Virology 185, 749-757) suggests that interruption of this region in the 180 residue truncated polypeptide may be responsible for its inability to confer protection and consequently that the 174-187 region may play a major role in the protection effected by the protein G. To support these hypotheses, we examined the ability of the amino acid region 124-203 of glycoprotein G to confer protection. The corresponding peptide was expressed as a non-fusion protein in a recombinant vaccinia virus designated VG27. Immunization of BALB/c mice with this recombinant efficiently induced the production of antibodies capable of recognizing both the parental glycoprotein G and peptide 174-187. Furthermore, upon challenge with RSV, a significant decrease of infectious particles was found in the lungs of mice immunized with VG27 as compared with non-immunized mice. Our results suggest that the 124-203 amino acid region of the RSV G protein constitutes a major part of the domain involved in protection.
引用
收藏
页码:303 / 315
页数:13
相关论文
共 10 条
  • [1] Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV
    Takimoto, T
    Hurwitz, JL
    Coleclough, C
    Prouser, C
    Krishnamurthy, S
    Zhan, XY
    Boyd, K
    Scroggs, RA
    Brown, B
    Nagai, Y
    Portner, A
    Slobod, KS
    JOURNAL OF VIROLOGY, 2004, 78 (11) : 6043 - 6047
  • [2] Disease severity of respiratory syncytial virus (RSV) infection correlate to a novel set of five amino acid substitutions in the RSV attachment glycoprotein (G) in China
    Li, Wanwei
    Wang, Yanlan
    Yu, Bo
    Tan, Qiqi
    Zhou, Jijian
    Hu, Jingjing
    Wu, Yuanbin
    Wang, Bo
    Li, Hongjian
    VIRUS RESEARCH, 2020, 281
  • [3] Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease
    Lee, Yu-Na
    Hwang, Hye Suk
    Kim, Min-Chul
    Lee, Young-Tae
    Cho, Min-Kyoung
    Kwon, Young-Man
    Lee, Jong Seok
    Plemper, Richard K.
    Kang, Sang-Moo
    VIROLOGY, 2015, 476 : 217 - 225
  • [4] Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
    Caidi, Hayat
    Harcourt, Jennifer L.
    Tripp, Ralph A.
    Anderson, Larry J.
    Haynes, Lia M.
    PLOS ONE, 2012, 7 (12):
  • [5] Chimeric Bovine/Human Parainfluenza Virus Type 3 Expressing Respiratory Syncytial Virus (RSV) F Glycoprotein: Effect of Insert Position on Expression, Replication, Immunogenicity, Stability, and Protection against RSV Infection
    Liang, Bo
    Munir, Shirin
    Amaro-Carambot, Emerito
    Surman, Sonja
    Mackow, Natalie
    Yang, Lijuan
    Buchholz, Ursula J.
    Collins, Peter L.
    Schaap-Nutt, Anne
    JOURNAL OF VIROLOGY, 2014, 88 (08) : 4237 - 4250
  • [6] A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV)
    Huang, Y
    Anderson, R
    VACCINE, 2003, 21 (19-20) : 2500 - 2505
  • [7] Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model
    Brakel, Kelsey A.
    Binjawadagi, Basavaraj
    French-Kim, Kristen
    Watts, Mauria
    Harder, Olivia
    Ma, Yuanmei
    Li, Jianrong
    Niewiesk, Stefan
    VACCINE, 2021, 39 (47) : 6817 - 6828
  • [8] Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection
    Lee, Su-Hwa
    Chu, Ki-Back
    Kim, Min-Ju
    Mao, Jie
    Eom, Gi-Deok
    Yoon, Keon-Woong
    Ahmed, Md Atique
    Quan, Fu-Shi
    PHARMACEUTICS, 2023, 15 (03)
  • [9] A highly attenuated recombinant human respiratory syncytial virus lacking the G protein confers long time protection against RSV infection in cotton rats
    Boes, J.
    Luytjes, W.
    Roholl, P. J.
    Widjojoatmodjo, M. N.
    VACCINE, 2008,
  • [10] Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: The role of cysteinyl residues in protection
    Simard, C
    Nadon, F
    Seguin, C
    Thien, NN
    Binz, H
    Basso, J
    Laliberte, JF
    Trudel, M
    VACCINE, 1997, 15 (04) : 423 - 432